Bristol Myers Squibb: Accelerate Drug Development Through Machine Learning Image Classification

Drug discovery and development process are long, complex, and dependent on numerous factors. Machine learning can now help predict the physical and chemical properties of large molecules with improved efficiency and high accuracy. By leveraging AWS ML capabilities, companies like Bristol Myers Squibb have found new efficiencies to automate image classification process during protein crystallization. In this session, Bristol Myers Squibb and AWS Data Scientists share how they used Amazon SageMaker image cl